里昂：重申国药控股(01099)“买入”评级 目标价降至27港元
里昂发布报告称，国药控股(01099)去年末季业绩呈逐渐改善，因至去年底止内地医药打贪影响逐渐消退。去年末季公司收入按季升3.9%，纯利按季升48.5%至30亿元人民币。公司专注盈利扩张，料其医疗器材制造新兴业务将驱动利润扩张，重申“买入”评级，目标价由27.1港元略下调至27港元。
Reprinted from 引领外汇网，the copyright all reserved by the original author.
Disclaimer: The content above represents only the views of the author or guest. It does not represent any views or positions of FOLLOWME and does not mean that FOLLOWME agrees with its statement or description, nor does it constitute any investment advice. For all actions taken by visitors based on information provided by the FOLLOWME community, the community does not assume any form of liability unless otherwise expressly promised in writing.
FOLLOWME Trading Community Website: https://www.followme.com
If you like, reward to support.
Hot
No comment on record. Start new comment.